Found vs. Mochi Health for compounded GLP-1 programs
Summary
Two telehealth platforms that offer compounded GLP-1 options alongside membership fees. Both disclose that compounded medications are not FDA-approved. Operational facts verified on each official site on 2026-07-24.
At a glance
| Dimension | Found | Mochi Health |
|---|---|---|
| Membership fee | Included in $99/mo compounded tier | $39 first month, then $79/mo (medication separate) |
| Compounded medication price | $99/mo (compounded tier) | From $99 (semaglutide) / $199 (tirzepatide) |
| Coverage | All 50 states | Terms vary by state |
| FDA compounding disclosure | Distinguishes compounded from branded | Explicit FDA not-approved disclaimer |
Found
- Membership fee
- Included in $99/mo compounded tier
- Compounded medication price
- $99/mo (compounded tier)
- Coverage
- All 50 states
- FDA compounding disclosure
- Distinguishes compounded from branded
Mochi Health
- Membership fee
- $39 first month, then $79/mo (medication separate)
- Compounded medication price
- From $99 (semaglutide) / $199 (tirzepatide)
- Coverage
- Terms vary by state
- FDA compounding disclosure
- Explicit FDA not-approved disclaimer
What they have in common
- Both offer compounded GLP-1 options and disclose the non-FDA-approved status.
- Both are cash-pay-oriented telehealth platforms.
- We have no commercial relationship with either provider.
Material differences
- Found bundles medication into a flat $99/mo compounded tier; Mochi charges membership and medication separately.
- Found states nationwide coverage; Mochi notes terms vary by state.
Decision considerations
- That compounded medications are not FDA-approved or quality-reviewed.
- Whether medication is bundled or billed separately.
- Total monthly cost including all fees.
- That prices change — reconfirm on each official site.
Sources
- 1.Found (joinfound.com) — Found (official site). Provider official page(operational fact only — not independent evidence of safety or efficacy)Accessed July 24, 2026.
- 2.Mochi Health — Mochi Health (official site). Provider official page(operational fact only — not independent evidence of safety or efficacy)Accessed July 24, 2026.
- 3.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss — U.S. Food and Drug Administration. Government agencyAccessed July 24, 2026.
Last reviewed (yesterday)